Language
The official language of the symposium will be English. Simultaneous translation from English to Spanish and Portuguese and vice versa will be provided.
We offer our registered users tailored information, free online courses and exclusive content.
Our platform has been renewed. All users registered at any of the old websites are kindly requested to reset their password. Why is this?
... or you lost your password?The official language of the symposium will be English. Simultaneous translation from English to Spanish and Portuguese and vice versa will be provided.
Meridiano Congress
Project Coordinator: Titty Alvino
T +39 06 88 595 310 - F +39 06 88595 234
titty.alvino@meridiano.it
The registration fee is 200€ and includes:
• Scientific sessions
• Coffee breaks and luncheons
• Educational materials
• Certificate of attendance
Two of the most challenging global health emergencies of the 21st century are diabetes and hypertension. Both can progress to serious cardiovascular conditions which are the leading cause of death in developed countries; high blood pressure is still considered the highest worldwide risk factor for premature death. In 2015 alone, the International Diabetes Federation estimates that 415 million people were affected by diabetes – a number that is expected to rise over the next two decades. Patients with diabetes are at high risk of developing co morbidities which can cause disability, reduced quality of life and a raised risk of mortality. Pathogenesis of diabetes and hypertension is linked to modifiable risk factors such as diet and lifestyle as well as genetic predisposition. Both hypertension and diabetes are reaching epidemic proportions in Central and South America as both regions engage in increasingly Western lifestyles. Thyroid dysfunction, which poses complex medical problems and requires dedicated treatment, is also common in Latin America due to iodine deficiency as well as genetic factors. Even though modern medicine offers a plethora of therapeutic interventions for diabetes, hypertension and thyroid dysfunction, the management of these conditions is still an enormous burden on the global healthcare community – in part due to insufficient funding allocated to combating cardiometabolic diseases.
• Manage hypertension and related cardiovascular complications
• Apply the suggested algorithms for diabetes management
• Manage thyroid disorders
• Improve the proper use of oral antidiabetic agents in different conditions
• Manage the complexity of the relationship between hypertension, diabetes and thyroid disorders
An application has been made to the EACCME ® for CME accreditation of the EXCEMED conference 2016 Latin American conference on cardiometabolic diseases management: Health emergencies in focus to be held on 22-23 July 2016 in São Paulo, Brazil.
08.30 registration
09.00 Welcome and introduction
09.15 L1: Diabetes, how do we get there? K. Cruickshank (UK)
Video lecture, Slide presentation
09.40 L2: Lifestyle modifications to prevent diabetes: is it enough? P. L. Jaramillo (Colombia)
Video lecture (in Spanish), Slide presentation
10.05 L3: Drugs for type 2 diabetes prevention: which is better? Leticia Schwerz Weinert
Video lecture (in Portuguese), Slide presentation
10.30 Question time
11.00 coffee break
11.15 L4: Diabetes management: how to choose the right drug? E. Maddaloni (Italy)
11.40 L5: Gestational Diabetes: when and how should pharmacological intervention be implemented? Leticia Schwerz Weinert
Video lecture (in Portuguese), Slide presentation
12.05 L6: What is the role of new technologies in type 2 diabetes? Anna Rita Maurizi
Video lecture, Slide presentation
12.30 Question time
13.00 Lunch
14.00 L7: Cardiometabolic implications of thyroid dysfunction, G. Brenta (Argentina)
Video lecture, Slide presentation
14.25 L8: Subclinical hypothyroidism: myths, presumptions and facts, B. Biondi (Italy)
Video lecture, Slide presentation
14.50 L9: New perspectives in the diagnostic of thyroid nodules, G. Brenta (Argentina)
Video lecture, Slide presentation
15.15 Question time
15.45 coffee Break
16.00 Debate on optimizing metformin and combination therapy
Optimizing metform - K. Cruickshank (UK) VS. Combination therapy P. L. Jaramillo (Colombia)
16.20 Let’s talk
16.40 L10: Autonomic dysfunction in diabetes: the hidden diseases complicating blood pressure and heart rate control, V. Spallone (Italy)
Video lecture, Slide presentation
17.05 Question time
17.25 Take home messages
17.30 end of the first day
09.00 L11: Are hypertension and obesity linked? G. Grassi (Italy)
Video lecture, Slide presentation
09.25 L12: High heart rate and cardiovascular risk, G. Grassi (Italy)
Video lecture, Slide presentation
09.50 L13: Goal of treating patients with hypertension and coronary artery disease, Speaker to be announced
10.15 Question time
10.45 coffee Break
11.00 Debate on the management on blood pressure targets in hypertension
Blood pressure targets in hypertension: the evidence for sprint Speaker to be announced
VS.
Blood pressure targets in hypertension: the evidence against sprint G. Grassi (Italy)
11.20 Question time
11.40 L14: Is heart rate a target in hypertensive treatment? H. Struijker-Boudier (The Netherlands)
Video lecture, Slide presentation
12.05 L15: combination treatment: RAS blockers are not the only possibility - relevance of combination therapy in hypertension, S. Taddei (Italy)
Video lecture, Slide presentation
12.30 L16: The prevention of heart failure development in hypertension, María Juliana Rodríguez Gonzalez
Video lecture (in Spanish), Slide presentation
12.55 Question time
13.25 Take home messages
13.30 end of the conference
Closing lunch
Senior Programme Manager: Chloé Xilinas
T +39 06 420413 505 - F +39 06 420413 677
chloe.xilinas@excemed.org
Cardiologist Medical Advisor: Stefano Taddei
Endocrinologist Medical Advisor: Ernesto Maddaloni